124
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Long duration-mild whole body hyperthermia of up to 12 hours in rats: Feasibility, and efficacy on primary tumour and axillary lymph node metastases of a mammary adenocarcinoma: implications for adjuvant therapy

, , , , , & show all
Pages 89-98 | Received 16 Jan 1996, Accepted 22 Aug 1996, Published online: 09 Jul 2009

References

  • Armour E. P., McEachern D., Wang Z., Corry P. M., Martinez A. Sensitivity of human cells to mild hyperthermia. Cancer Research 1993; 53: 2740–2744
  • Baba H., Siddik Z. H., Strebel F. R., Jenkins G. N., Bull J. M. C. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling. Cancer Research 1989; 49: 7041–7044
  • Bull J. M. Systemic hyperthermia: background and principles. Hyperthermia in cancer therapy, F. K. Storm. G. K. Hall Medical Publishers, Boston, MA 1983; 401–405
  • Gerad H., Egorin M. J., Whitacre M., Van Echo D. A., Aisner J. Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloro-platinum (II) and whole body hyperthermia. Cancer Chemotherapy and Pharmacology 1983; 11: 162–166
  • Hahn G. M. Effect of hyperthermia on spread and growth of metastasis. Hyperthermia and cancer, G. M. Hahn. Plenum Press, NY 1982; 174–176
  • Hill S. A., Denekamp J. Does local tumor heating in mice influence metastatic spread?. British Journal of Radiology 1982; 55: 44–451
  • Mackey M. A., Anolik S. L., Roti Roti J. L. Cellular mechanisms associated with the lack of chronic ermotolerance expression in HeLa S3 cells. Cancer Research 1992; 52: 1101–1106
  • Manzella J. P., Roberts N. J. Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid, and hyperthermia. The Journal of Immunology 1979; 123: 1940–1944
  • Neri A., Welch D., Kawaguchi T., Nicolson G. L. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. Journal of the National Cancer Institute 1982; 68: 507–517
  • Ohno S., Strebel F. R., Stephens L. C., Siddik Z. H., Makino M., Klostergaard J., Tomasovic S. P., Khokhar A. R., Bull J. M. C. Increased therapeutic efficacy induced by tumor necrosis factor α combined with platinum complexes and whole body hyperthermia in rats. Cancer Research 1992; 52: 4096–4101
  • Overgaard J., Overgaard M. Influence of hyperthermia on the immune status; experimental basis and clinical application in cancer patients. Immunodiagnosis and immunotherapy of malignant tumors, H. D. Flad, C. Herfarth, M. Betzler. Springer-Verlag, Berlin 1979; 247–265
  • Overgaard J., Gonzalez D. G., Hulshof M. C. C., Arcangeli G., Dahl O., Mella O., Bentzen S. M. Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995; 345: 540–543
  • Pettigrew R. T., Galt J. M., Ludgate C. M., Horn D. B., Smith A. N. Circulatory and biochemical effects of whole body hyperthermia. British Journal of Surgery 1974; 61: 727–130
  • Raaphorst G. P., Mao J., Ng C. E. Thermotolerance in human glioma cells. International Journal of Hyperthermia 1995; 11: 523–529
  • Roberts N. J., Sandberg K. Hyperthermia and human leukocyte function, II. Enhanced production of and response to leukocyte migration inhibition factor (LIF). The Journal of Immunology 1979; 122: 1990–1993
  • Roszkowski W., Wrembel J. M., Roszkowski K., Janiac M., Szmigielski S. Effect of whole-body hyperthermia on delayed cutaneous hypersensitivity in tumor-bearing mice. Journal of Cancer Research and Clinical Oncology 1980; 97: 23–29
  • Sakaguchi Y., Makino M., Kaneko T., Stephens L. C., Strebel F. R., Danhauser L. L., Jenkins G. N., Bull J. M. C. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Research 1994; 54: 2223–2227
  • Sapareto S. A., Hopwood L. E., Dewey W. C., Raju M. R., Gray J. W. Effects of hyperthermia on survival and progression of Chinese hamster ovary cells. Cancer Research 1978; 38: 393–400
  • Schechter M., Stowe S. M., Moroson H. Effects of hyperthermia on primary and metastatic growth and host immune response in rats. Cancer Research 1978; 38: 498–502
  • Shah S. A., Dickson J. A. Effect of hyperthermia on the immune response of normal rabbits. Cancer Research 1978; 38: 3518–3522
  • Skeen M. J. Influences of hyperthermia on immunological functions. Hyperthermia in cancer treatment, A. Leopold. CRC Press, Inc., Boca Raton, FL 1986; 93–105
  • Sugimachi K., Kuwano H., Ide H., Toge T., Saku M., Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with esophageal carcinoma: a prospective randomized trial. International Journal of Hyperthermia 1995; 10: 485–493
  • Smith J. B., Knowlton R. P., Agarwal S. Human lymphocyte responses are enhanced by culture at 40°C. The Journal of Immunology 1978; 121: 691–194
  • Welch D. R., Neri A., Nicolson G. L. Comparison of ‘spontaneous’ and ‘experimental’ metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis 1983; 3: 65–80
  • Westra A., Dewey W. C. Variation in sensitivity to heat shock during the cell cycle of Chinese hamster cells in vitro. International Journal of Radiation Biology 1971; 19: 467–477
  • Wondergem J., Bulger R. E., Strebel F. R., Newman R. A., Travis E. L., Stephens L. C., Bull J. M. C. Effect of cis-diamminedichloroplatinum (II) combined with whole body hyperthermia on renal injury. Cancer Research 1988; 48: 440–446

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.